XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3

Note 13 - Segment Information (Tables)

9 Months Ended

Sep. 30, 2023

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Thirteen Weeks Ended September 30, 2023		Specialty Health Care				Engineering				Life Sciences and IT				Corporate				Total
Revenue		$	24,895			$	22,452			$	10,702			$	-			$	58,049
Cost of services			17,438				16,846				6,484				-				40,768
Gross profit			7,457				5,606				4,218				-				17,281
Selling, general and administrative			5,977				4,327				2,358				-				12,662
Depreciation and amortization of property and equipment			88				122				33				-				243
Amortization of acquired intangible assets			-				-				45				-				45
Operating income			1,392				1,157				1,782			$	-			$	4,331
Total assets as of September 30, 2023		$	32,272			$	45,949			$	17,662			$	5,331			$	101,214
Property and equipment acquired		$	62			$	162			$	69			$	22			$	315

Thirteen Weeks Ended October 1, 2022		Specialty Health Care				Engineering				Life Sciences and IT				Corporate				Total
Revenue		$	27,997			$	20,922			$	9,233			$	-			$	58,152
Cost of services			19,014				15,594				6,186				-				40,794
Gross profit			8,983				5,328				3,047				-				17,358
Selling, general and administrative			5,933				4,531				2,087				-				12,551
Depreciation and amortization of property and equipment			101				136				29				-				266
Gain on sale of assets			-				(219	)			-				-				(219	)
Operating income		$	2,949			$	880			$	931			$	-				4,760
Total assets as of October 1, 2022		$	33,280			$	32,343			$	8,579			$	2,607			$	76,809
Capital expenditures		$	9			$	207			$	39			$	266			$	521

Thirty-Nine Weeks Ended September 30, 2023		Specialty Health Care				Engineering				Life Sciences and IT				Corporate				Total
Revenue		$	99,553			$	61,956			$	30,700			$	-			$	192,209
Cost of services			70,623				47,482				19,039				-				137,144
Gross profit			28,930				14,474				11,661				-				55,065
Selling, general and administrative			19,211				12,626				6,945				-				38,782
Depreciation and amortization of property and equipment			281				370				105				-				756
Amortization of acquired intangible assets			-				-				136				-				136
Gain on sale of assets			-				(395	)			-			$	-				(395	)
Operating income			9,438				1,873				4,475								15,786
Total assets as of September 30, 2023		$	32,272			$	45,949			$	17,662			$	5,331			$	101,214
Property and equipment acquired		$	109			$	640			$	88			$	38			$	875

Thirty-Nine Weeks Ended October 1, 2022		Specialty Health Care				Engineering				Life Sciences and IT				Corporate				Total
Revenue		$	123,638			$	61,726			$	29,095			$	-			$	214,459
Cost of services			86,772				45,653				19,573				-				151,998
Gross profit			36,866				16,073				9,522				-				62,461
Selling, general and administrative			21,203				12,659				6,100				-				39,962
Depreciation and amortization of property and equipment			322				332				75				-				729
Gain on sale of assets			-				(219	)			-				-				(219	)
Operating income		$	15,341			$	3,301			$	3,347			$	-			$	21,989
Total assets as of October 1, 2022		$	33,280			$	32,343			$	8,579			$	2,607			$	76,809
Capital expenditures		$	57			$	496			$	102			$	275			$	930

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	Thirteen Weeks Ended								Thirty-Nine Weeks Ended
	September 30, 2023				October 1, 2022				September 30, 2023				October 1, 2022
Revenue
United States	$	53,679			$	55,180			$	179,800			$	205,162
Canada		1,647				1,091				5,060				3,555
Puerto Rico		1,643				1,261				4,745				3,760
Europe		1,080				620				2,604				1,982
	$	58,049			$	58,152			$	192,209			$	214,459

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	September 30, 2023				December 31, 2022
Total assets
United States	$	91,141			$	81,558
Canada		1,829				1,640
Puerto Rico		4,157				1,401
Europe		4,087				3,365
	$	101,214			$	87,964

X

- Definition

Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-25

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration